Schedule 13G ownership disclosure
KEMPHARM, INC
Security class unavailable · CUSIP: 488445107
Event date: 2019-06-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000892712-19-000251
- Form type
- SC 13G
- Filer
- ZEVRA THERAPEUTICS, INC.
- CIK
- CIK 1434647
- Filed
- Jun 11, 2019
- Reporting period
- Jun 03, 2019
- Description
- Schedule 13G beneficial ownership